This is a double blind randomized clinical trial with placebo in which we evaluate the effect of modified Nigella Sativa capsule on the menstrual bleeding frequency, duration and volume in Poly Cystic Ovary (PCO) patients with oligomenorrhea or amenorrhea and compared it with those of placebo. This is a multi-central trial. According to the National Institute of Health criteria, the gynecologist selects eligible women with PCO with oligomenorrhea or amenorrhea; candidates enter the study if do not have any other systemic disease (e.g., diabetes, hyperprolactinemia, thyroid disorders, chronic liver and kidney diseases, and epilepsy) be pregnant or lactating. A sample of 68 patients will randomly be divided into two groups of 34, one group will receive the Nigella Sativa and the other one placebo capsule. First, the hormonal and biochemical tests will be performed on all patients, which will be repeated at the end of the study for patients who show abnormal results. A 2 g/day Black Cumin, 4 capsules of 500 mg, will be taken two times per day for one month. The medication will be stoped if menstruation occurs. The treatment duration will be three months; the medication consumption must be delayed for one week in case the menstruation does not occur, resulting in a four-month treatment duration. The placebo will be prescribed the same as the Nigella Sativa capsule, i.e. 4 capsules for a total of 2 grams. The outcomes of this study are menstruation frequency and the menstrual bleeding duration and volume.